Unstable angina is a type of chest pain caused by reduced blood flow to the heart that occurs unpredictably, either at rest, for the first time, or with worsening intensity compared to previous episodes. It falls under the umbrella of acute coronary syndromes, alongside heart attacks, and is considered a medical emergency because it signals that a heart attack could be imminent. Roughly 13% of patients hospitalized with unstable angina go on to have a heart attack during that same hospital stay.
What Happens Inside the Artery
The underlying cause is almost always a buildup of fatty deposits, called plaques, inside the coronary arteries. These plaques have a soft, lipid-rich core covered by a fibrous cap made of collagen. In unstable angina, that cap cracks or erodes, exposing the material underneath to the bloodstream. The body responds to this like it would to a wound: platelets rush to the site, clump together, and begin forming a blood clot.
This clot partially blocks the artery, cutting off some blood flow to the heart muscle. What happens next depends on a tug-of-war between the body’s clotting system and its clot-dissolving system. The clot might grow and completely block the artery (causing a heart attack), break apart and send fragments downstream, or dissolve on its own and leave behind a narrower artery. Unstable angina specifically means the blockage is enough to cause symptoms but hasn’t yet killed heart tissue.
Plaques that rupture tend to be more “active” than stable ones. They contain higher concentrations of tissue factor, a protein that supercharges clot formation. Plaques from patients with unstable angina contain more than twice the tissue factor found in plaques from patients with stable angina, and the areas richest in tissue factor overlap with zones of intense immune cell activity. In other words, inflammation inside the artery wall is a key driver of instability.
How It Feels
The classic symptom is chest pressure, tightness, or squeezing that can radiate to the jaw, neck, shoulders, or arms. What separates unstable angina from the stable kind is the pattern. It shows up in one of three ways:
- Rest angina: chest pain that occurs without any physical exertion or emotional stress
- New-onset angina: chest pain that appears for the first time, particularly if it limits normal activity
- Crescendo angina: previously stable chest pain that becomes more frequent, lasts longer, or feels more severe than before
Many people with unstable angina already have a history of coronary artery disease. They notice that the chest pain they’ve lived with for months or years has shifted, coming on with less effort, lasting longer, or responding less reliably to rest or nitroglycerin.
Atypical Symptoms
Not everyone experiences textbook chest pain. Women, older adults, and people with diabetes are more likely to have atypical symptoms: shortness of breath, dizziness, sweating, nausea or vomiting, palpitations, back pain, or extreme fatigue. In one hospital study, about 85% of women with acute coronary events presented with these atypical symptoms, compared to 70% of men. This mismatch between expectation and reality is one reason heart problems in women are sometimes recognized late.
How Doctors Distinguish It From a Heart Attack
Unstable angina, heart attack with minor damage (NSTEMI), and heart attack with major damage (STEMI) all fall on a spectrum. The critical dividing line between unstable angina and a heart attack is troponin, a protein released into the blood when heart muscle cells die. In unstable angina, troponin levels stay normal. If troponin rises above the 99th percentile of the normal range, the diagnosis shifts to heart attack.
An electrocardiogram (ECG) provides additional clues. New changes in the ST segment or T waves suggest active ischemia, though these changes can be subtle. ST depression of half a millimeter or more, or T wave inversions, increase the likelihood of an acute coronary syndrome. Neither test alone is definitive, which is why emergency departments typically draw blood for troponin multiple times over several hours and perform serial ECGs.
Risk Factors That Raise the Stakes
Not all episodes of unstable angina carry the same level of danger. Doctors use scoring tools to estimate a patient’s short-term risk of heart attack or death. The most widely used, the TIMI risk score, assigns one point each for factors including age 65 or older, having three or more traditional risk factors for heart disease (high blood pressure, diabetes, smoking, family history, high cholesterol), known coronary artery narrowing of 50% or greater, ST-segment changes on an ECG, and two or more angina episodes within 24 hours. Higher scores push toward more aggressive treatment.
Acute Treatment
Treatment begins immediately with the goal of preventing the partial blockage from becoming a complete one. The foundation is antiplatelet therapy: aspirin plus a second blood-thinning medication that blocks a different platelet activation pathway. Current guidelines from the American College of Cardiology and American Heart Association recommend dual antiplatelet therapy for up to one year after an acute coronary syndrome in patients who don’t have a high bleeding risk.
Blood thinners (anticoagulants) are also started in the hospital to keep the clot from growing. For patients managed without a stent procedure, injectable anticoagulants are preferred over intravenous heparin.
Beyond clot prevention, treatment targets the mismatch between the heart’s oxygen supply and demand. Medications that slow the heart rate and lower blood pressure reduce how hard the heart has to work. Nitroglycerin dilates the coronary arteries to improve blood flow.
Stent Procedures vs. Medication Alone
Some patients with unstable angina need a catheterization procedure, where a cardiologist threads a thin tube into the blocked artery, inflates a tiny balloon to widen it, and places a stent to hold it open. This is called percutaneous coronary intervention (PCI). The decision depends on how severe the blockage is, how much heart muscle is at risk, and how the patient responds to initial medical therapy.
For patients whose symptoms stabilize quickly on medication and whose risk scores are low, a conservative approach with medication alone can be equally effective. A meta-analysis of 28 randomized controlled trials involving nearly 19,000 patients with stable angina found no differences between PCI and medical management in rates of heart attack, stroke, or death. However, unstable angina with ongoing symptoms, high-risk features, or significant blockages generally tips the balance toward intervention.
Long-Term Prevention
An episode of unstable angina is a warning. The same process that cracked one plaque can happen again elsewhere, so long-term management focuses on stabilizing every plaque in the coronary arteries, not just the one that caused trouble.
Cholesterol-lowering therapy is the cornerstone. Guidelines recommend high-intensity statin therapy to cut LDL cholesterol by at least 50%. For patients considered very high risk, the target is an LDL below 70 mg/dL (U.S. guidelines) or below 55 mg/dL (European guidelines). If a statin alone doesn’t get there, additional medications can be layered on to push LDL lower. Both sets of guidelines emphasize that LDL plays a direct, causal role in plaque formation, making aggressive lowering a priority rather than an optional goal.
Beyond medication, the modifiable risk factors matter enormously: quitting smoking, managing blood pressure and blood sugar, maintaining a healthy weight, and staying physically active. Cardiac rehabilitation programs, which combine supervised exercise with education and lifestyle coaching, improve outcomes and are typically offered after any acute coronary event. The combination of medication and sustained lifestyle changes gives the best chance of keeping plaques stable and arteries open for the long term.